Medroxyprogesterone Injection (400 mg/mL) and Tofacitinib Citrate
Determining the interaction of Medroxyprogesterone Injection (400 mg/mL) and Tofacitinib Citrate and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: medroxyprogesterone
Brand name: Provera, Depo-Provera, Depo-subQ provera 104, Depo-Provera Contraceptive
Synonyms: Medroxyprogesterone, MedroxyPROGESTERone
Generic Name: tofacitinib
Brand name: Xeljanz, Xeljanz XR
Synonyms: Tofacitinib
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Medroxyprogesterone Injection (400 mg/mL)-Tofacitinib Extended-Release Tablets
- Medroxyprogesterone Injection (400 mg/mL)-Tofacitinib Tablets
- Medroxyprogesterone Injection (400 mg/mL)-Tofranil
- Medroxyprogesterone Injection (400 mg/mL)-Tofranil injection
- Medroxyprogesterone Injection (400 mg/mL)-Tofranil-PM
- Medroxyprogesterone Injection (400 mg/mL)-Tol-Tab
- Tofacitinib Citrate-Medroxyprogesterone Injection (Intramuscular)
- Tofacitinib Citrate-Medroxyprogesterone Injection (Subcutaneous)
- Tofacitinib Citrate-Medroxyprogesterone Injection ER
- Tofacitinib Citrate-Medroxyprogesterone Intramuscular
- Tofacitinib Citrate-Medroxyprogesterone Tablets
- Tofacitinib Citrate-Medworx Patch